Volume 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress                   Multidiscip Cancer Investig 2017, 1 - Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress: 0-0 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Derogar P, Abolfathi A A, Safi Samghabadi A, Yazdani A, Afkhami F. A Comparison Between Malignant Breast Neoplasms Apoptosis and Benign Breast Neoplasms Under Influence of DNA Fragmentation. Multidiscip Cancer Investig 2017; 1
URL: http://mcijournal.com/article-1-85-en.html
Abstract:   (5210 Views)
Introduction: Interrelationship of cells proliferation and apoptosis regulate homeostasis in normal tissues. Breast cancer development is mainly due to defective apoptosis pathway. Since there is a significant interrelationship between the ratio of apoptotic bodies to normal cells and breast cancer pathogenesis, we conducted this study to contrast malignant breast neoplasms apoptosis with benign breast neoplasms under the influence of DNA Fragmentation.
Materials and Methods: Sixty patients entered this study. Its control group were their both benign neoplasms and normal cells. After DNA extraction, DNA fragmentation was carried out with DNA laddering assay. Apoptotic bodies were detected in 1% agarose gel electrophoresis.
Results: Apoptotic bodies were detected in 83.3% of breast cancer samples. However, no sign of apoptosis was observed in control samples and the number of positive cases in malignant samples was significantly higher than benign samples (P< 0.05).
Conclusions: It is revealed that the rate of apoptosis detectable by DNA fragmentation in malignant breast neoplasms is higher than benign types so that it can be used as a quick-diagnostic technique.
Full-Text [PDF 61 kb]   (1726 Downloads)    
Select article type: Original/Research Article | Subject: Materials Science and Nanomedicine
Received: 2017/10/25 | Accepted: 2017/10/25 | ePublished: 2017/10/25

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb